Covid and Brain Damage

Covid and Brain Damage

#Dementia #neurological "#brain injury"
The widespread šŸ§  neuro issues Iā€™m witnessing canā€™t be overstated; a tipping point of previously healthy adults into early Parkinsonā€™s/ GBS/ dementia/ ALS/ serious šŸ‘ļø issues/ strokes/ tremors/ vertigo / intractable anosmia & tinnitus etc
The widespread šŸ§  neuro issues Iā€™m witnessing canā€™t be overstated; a tipping point of previously healthy adults into early Parkinsonā€™s/ GBS/ dementia/ ALS/ serious šŸ‘ļø issues/ strokes/ tremors/ vertigo / intractable anosmia & tinnitus etc

ā€œThe widespread šŸ§  neuro issues Iā€™m witnessing canā€™t be overstated; a tipping point of previously healthy adults into early Parkinsonā€™s/ GBS/ dementia/ ALS/ serious šŸ‘ļø issues/ strokes/ tremors/ vertigo / intractable anosmia & tinnitus etc

An unparalleled horror show & crime.ā€

Ā·x.comĀ·
The widespread šŸ§  neuro issues Iā€™m witnessing canā€™t be overstated; a tipping point of previously healthy adults into early Parkinsonā€™s/ GBS/ dementia/ ALS/ serious šŸ‘ļø issues/ strokes/ tremors/ vertigo / intractable anosmia & tinnitus etc
Pioneering discovery and therapeutics at the brain-vascular-immune interface
Pioneering discovery and therapeutics at the brain-vascular-immune interface

A new paper in Cell, ā€œPioneering discovery and therapeutics at the brain-vascular-immune interface,ā€ describes COVID-19 as a neurological disease alongside multiple sclerosis, Alzheimerā€™s, stroke and traumatic brain injury.

ā€œCOVID-19 can accelerate progression of dementia and induce BBB disruption and inflammatory blood clots causally linked with neuroinflammation and neuronal loss.8 In neurodevelopmental disorders, prematurity and perinatal hypoxia that trigger brain hemorrhage and BBB disruption are risk factors for cerebral palsy, intellectual disability, and autism. Collectively, these risk factors highlight the interconnected vascular and immune triggers of neurological diseases.ā€

Ā·cell.comĀ·
Pioneering discovery and therapeutics at the brain-vascular-immune interface